Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 12:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2209–2232 of 2,761 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Schizophrenia
Interventions: TMS; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 64 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Nonsuicidal Self Injury, Suicidal Ideation, Depression, Anxiety
Interventions: Self-guided digital intervention for NSSI, Digital intervention for NSSI with coaching, Active control; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiovascular Diseases
Interventions: Filtered Air; Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 49 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Acute Lymphoblastic Leukemia, Pediatric
Interventions: Pegaspargase, Erwinia asparaginase, Cyclophosphamide, CYTARABINE, DASATINIB, DEXAMETHASONE, Dexrazoxane, Doxorubicin, ETOPOSIDE, HYDROCORTISONE, LEUCOVORIN CALCIUM, MERCAPTOPURINE, METHOTREXATE, NELARABINE, Vincristine; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 1 Year to 21 Years
Enrollment: 560 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2034
U.S. locations: 7
States / cities: Boston, Massachusetts • New Brunswick, New Jersey • Buffalo, New York + 3 more

Conditions: Hypertension, Rheumatoid Arthritis
Interventions: Blood pressure intervention arm; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Opioid Misuse, Trauma Injury
Interventions: Opioid Risk Monitoring (ORM), enhanced Trauma Care Coordination (eTCC), Pain Coping Skills Training - Brief (PCST-LITE), Standard Trauma Care Coordination (sTCC), Pain Coping Skills Training - Plus (PCST+), Pain Coping Skills Training - Maintenance (PCST-M); Other · Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: Temporomandibular Joint and Muscle Disorder
Interventions: Biobehavioral, Active Coping/Attention Intervention; Behavioral
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years and older
Enrollment: 456 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Advanced Solid Malignant Tumors, Advanced Ovarian Cancer
Interventions: U3-1565; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 4
States / cities: Detroit, Michigan • Oklahoma City, Oklahoma • Philadelphia, Pennsylvania + 1 more

Conditions: Smoking Cessation
Interventions: Empowering Cessation for the ACS South; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 100 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Cystic Fibrosis, Fatigue
Interventions: CF Wellness Program Sessions; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Baltimore, Maryland • Seattle, Washington

Conditions: Catastrophization
Interventions: Cognitive Therapy, Routine Care; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Kidney Disease, Kidney Transplant, Deceased Donor Kidney Transplant, Living Donor Kidney Transplantation, Chronic Kidney Disease (Stages 3b-5)
Interventions: Digital Health Integration, Training for Early Transplant Access and Support, Kidney Health Mobile Health (mHealth) Application; Behavioral
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Anxiety, Hypertension
Interventions: Clonidine Pill, Hydrochlorothiazide; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 79 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Young Adults
Interventions: Transcranial direct current stimulation; Device
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years to 25 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Physical Deconditioning
Interventions: IntenSive Therapeutic Rehabilitation for Older Skilled Nursing Home Residents; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: HIV Infection, Osteopenia, Osteoporosis
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Leiomyosarcoma
Interventions: Ontorpacept (TTI-621), Doxorubicin; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 23
States / cities: Santa Monica, California • Jacksonville, Florida • Tampa, Florida + 16 more

Conditions: Treatment Resistant Depression
Interventions: Genotyping assays; Genetic
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes Mellitus (T2DM)
Interventions: Disfrutando; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Columbia, Missouri • Kansas City, Missouri

Conditions: Stroke
Interventions: High Frequency rTMS, Sham rTMS; Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Dental Pain
Interventions: Oxycodone, Buprenorphine, Placebo Film, Placebo Capsule; Drug
Lead sponsor: BioDelivery Sciences International; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 3
States / cities: Austin, Texas • San Marcos, Texas • Salt Lake City, Utah

Conditions: Small-cell Lung Cancer, Large Cell Neuroendocrine Carcinoma of the Lung, Extrapulmonary Small Cell Carcinoma
Interventions: Abemaciclib,; Drug
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 19 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Yoga
Interventions: High-speed yoga, Low-speed yoga; Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 40 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Obesity
Interventions: Standard Behavioral Weight Loss Intervention, Dietary Goal: Reduction in Energy Density of Dietary Intake, Dietary Goal: Reduction of Energy Intake; Behavioral
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 21 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Knoxville, Tennessee

Search by objective public record fields.

Medial-prefrontal Enhancement During Schizophrenia Systems Imaging

Digital Mental Health Intervention for Nonsuicidal Self-Injury in Young Adults

Effect of Commute Traffic on Vascular Function

Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents

Improving Hypertension Control in Rheumatoid Arthritis

Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

An Implementation and Biobehavioral Study of Temporomandibular Joint and Muscle Disorder (TMJMD)

Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Empowering Cessation ACS South Region

Acceptability, Feasibility and Preliminary Efficacy of CFWP to Treat Clinically Elevated Fatigue in Adults With CF

Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects

Strategies to Transform Kidney Care and Improve Pursuit of Transplant

Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System

Inhibitory Control: Effects of Modulation

Shifting Rehabilitation Paradigms in Skilled Nursing Facilities

Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis

A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma

Pharmacogenomics for Antidepressant Guidance and Education

Effectiveness of and Implementation Strategies for 'Disfrutando'.

rTMS Combined With BWSTT in Stroke With Body Weight Supported Treadmill Training (BWSTT) After Stroke

Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain

Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC

Electromyography and Yoga

The Healthy Eating Choices for Life Program